Literature DB >> 7927662

C9-mediated killing of bacterial cells by transferred C5b-8 complexes: transferred C5b-9 complexes are nonbactericidal.

K P Blanchard1, J R Dankert.   

Abstract

The formation of the C5b-9 complex on the outer membrane of complement-sensitive cells of Escherichia coli results in inhibition of inner membrane function and the death of the cell. Cells bearing a precursor of the C5b-9 site, the C5b-8 complex, suffer no loss in viability. Antibiotic-sensitive, complement-sensitive donor cells bearing precursor C5b-8 complexes were incubated with equal numbers of antibiotic-resistant, complement-sensitive acceptor cells that had not been exposed to a complement source. This cell mixture was incubated with 5 mM EDTA for 5 min and then with calcium chloride (20 mM) for various times. The excess calcium ion concentration was effectively reduced with additional EDTA, and the cell mixture was washed and resuspended in buffer. The viability of the acceptor cells was assayed by plating on antibiotic-containing media. C9 was added to the mixture, and the mixture was incubated for 10 min at 37 degrees C and then plated as described above. It was found that the acceptor cells were killed by the addition of purified C9 only after incubation with donor cells bearing C5b-8 sites during the transfer procedure. This indicates that precursor C5b-8 sites that support C9-mediated killing could be transferred between cells. No loss in viability was detected for acceptor cells subjected to the procedure described above in the presence of donor cells bearing complete C5b-9 complexes, formed prior to mixing with acceptor cells for the transfer procedure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927662      PMCID: PMC303082          DOI: 10.1128/iai.62.10.4101-4106.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Areas of adhesion between wall and membrane of Escherichia coli.

Authors:  M E Bayer
Journal:  J Gen Microbiol       Date:  1968-10

2.  Metabolically controlled killing of Pasteurella septica by antibody and complement.

Authors:  E Griffiths
Journal:  Biochim Biophys Acta       Date:  1974-10-08

3.  Membrane topology and mutational analysis of the TolQ protein of Escherichia coli required for the uptake of macromolecules and cell envelope integrity.

Authors:  A Vianney; T M Lewin; W F Beyer; J C Lazzaroni; R Portalier; R E Webster
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

4.  Re-incorporation of the terminal C5b-9 complement complex into lipid bilayers: formation and stability of reconstituted liposomes.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

5.  Role of the TonB amino terminus in energy transduction between membranes.

Authors:  J C Jaskula; T E Letain; S K Roof; J T Skare; K Postle
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

Review 6.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.

Authors:  S L MacKay; J R Dankert
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  Identification of the outer membrane protein of E. coli that produces transmembrane channels in reconstituted vesicle membranes.

Authors:  T Nakae
Journal:  Biochem Biophys Res Commun       Date:  1976-08-09       Impact factor: 3.575

9.  Isolation of the terminal complement complex from target sheep erythrocyte membranes.

Authors:  S Bhakdi; P Ey; B Bhakdi-Lehnen
Journal:  Biochim Biophys Acta       Date:  1976-02-06

10.  Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

Authors:  C M Verduin; M Jansze; C Hol; T E Mollnes; J Verhoef; H van Dijk
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.